Kenana Al Adem - Search Results

Year	Number of Results
2017	1
2020	3
2022	4
2023	5
2024	0

1

Structural polymorphism and cytotoxicity of brain-derived β-amyloid extracts.

Al Adem K, Lee S. Al Adem K, et al. Protein Sci. 2023 May;32(5):e4639. doi: 10.1002/pro.4639. Protein Sci. 2023. PMID: 37051675 Free PMC article. Review.

2

Implantable Systems for Stress Urinary Incontinence.

Al Adem KM, Bawazir SS, Hassen WA, Khandoker AH, Khalaf K, McGloughlin T, Stefanini C. Al Adem KM, et al. Ann Biomed Eng. 2017 Dec;45(12):2717-2732. doi: 10.1007/s10439-017-1939-9. Epub 2017 Oct 11. Ann Biomed Eng. 2017. PMID: 29022114 Review.

3

Optoacoustic biomarkers of lipids, hemorrhage and inflammation in carotid atherosclerosis.

Karlas A, Fasoula NA, Kallmayer M, Schäffer C, Angelis G, Katsouli N, Reidl M, Duelmer F, Al Adem K, Hadjileontiadis L, Eckstein HH, Ntziachristos V. Karlas A, et al. Among authors: al adem k. Front Cardiovasc Med. 2023 Nov 9;10:1210032. doi: 10.3389/fcvm.2023.1210032. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 38028502 Free PMC article. Review.

4

Inhibition of SARS-CoV-2 Entry into Host Cells Using Small Molecules.

Al Adem K, Shanti A, Stefanini C, Lee S. Al Adem K, et al. Pharmaceuticals (Basel). 2020 Dec 8;13(12):447. doi: 10.3390/ph13120447. Pharmaceuticals (Basel). 2020. PMID: 33302344 Free PMC article. Review.

5

2D MXenes for controlled releases of therapeutic proteins.

Seitak A, Shanti A, Al Adem K, Farid N, Luo S, Iskandarov J, Karanikolos GN, Liao K, Chan V, Lee S. Seitak A, et al. Among authors: al adem k. J Biomed Mater Res A. 2023 Apr;111(4):514-526. doi: 10.1002/jbm.a.37469. Epub 2022 Nov 13. J Biomed Mater Res A. 2023. PMID: 36371793

6

Aggregation and Cellular Toxicity of Pathogenic or Non-pathogenic Proteins.

Lee S, Choi MC, Al Adem K, Lukman S, Kim TY. Lee S, et al. Among authors: al adem k. Sci Rep. 2020 Mar 20;10(1):5120. doi: 10.1038/s41598-020-62062-3. Sci Rep. 2020. PMID: 32198463 Free PMC article.

7

Hydrogen phosphate selectively induces MDA MB 231 triple negative breast cancer cell death in vitro.

Shanti A, Al Adem K, Stefanini C, Lee S. Shanti A, et al. Among authors: al adem k. Sci Rep. 2022 Mar 29;12(1):5333. doi: 10.1038/s41598-022-09299-2. Sci Rep. 2022. PMID: 35351930 Free PMC article.

8

Key Allosteric and Active Site Residues of SARS-CoV-2 3CLpro Are Promising Drug Targets.

Al Adem K, Ferreira JC, Fadl S, Mustafa M, Rabeh WM. Al Adem K, et al. Biochem J. 2023 May 31:BCJ20230027. doi: 10.1042/BCJ20230027. Online ahead of print. Biochem J. 2023. PMID: 37254750

9

Linking Alzheimer's Disease and Type 2 Diabetes: Characterization and Inhibition of Cytotoxic Aβ and IAPP Hetero-Aggregates.

Al Adem K, Shanti A, Srivastava A, Homouz D, Thomas SA, Khair M, Stefanini C, Chan V, Kim TY, Lee S. Al Adem K, et al. Front Mol Biosci. 2022 Mar 17;9:842582. doi: 10.3389/fmolb.2022.842582. eCollection 2022. Front Mol Biosci. 2022. PMID: 35372522 Free PMC article.

10

pH profiles of 3-chymotrypsin-like protease (3CLpro) from SARS-CoV-2 elucidate its catalytic mechanism and a histidine residue critical for activity.

Al Adem K, Ferreira JC, Fadl S, Rabeh WM. Al Adem K, et al. J Biol Chem. 2023 Feb;299(2):102790. doi: 10.1016/j.jbc.2022.102790. Epub 2022 Dec 9. J Biol Chem. 2023. PMID: 36509143 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

11 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year